Avadel Pharmaceuticals PLC
F:AWK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avadel Pharmaceuticals PLC
F:AWK
|
IE |
|
O
|
Orbis Se
DUS:OBS
|
DE |
|
S
|
SynBiotic SE
XMUN:SBX
|
DE |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AWK's stock price target?
Not Available
AWK does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Avadel Pharmaceuticals PLC?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 4 years is 31%.